Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Intensive testosterone-blocking therapy delays prostate-specific antigen progression in BRPC
31 Jan 2024
bởiJairia Dela Cruz
A 52-week course of intensified androgen-deprivation therapy (ADT) appears to extend prostate-specific antigen progression-free survival (PSA-PFS) in patients with biochemically recurrent prostate cancer (BRPC) compared with ADT alone, without prolonging time to testosterone recovery, according to the phase III open-label PRESTO trial.
Intensive testosterone-blocking therapy delays prostate-specific antigen progression in BRPC
31 Jan 2024TDM offers benefits in thiopurine-treated children with leukaemia, IBD
29 Jan 2024
Therapeutic drug monitoring (TDM) helps identify children treated by thiopurine for acute lymphoblastic leukaemia (ALL) and inflammatory bowel disease (IBD) who have not reached their target levels or are over treated, reports a recent study.